Facing entry of follow-up drugs, Tamiflu to be launched in a new formation

‘Tamiflu,’ an antiviral drug which soon will face the entry of follow-up drugs due to the expiration of its substance patent, has attracted attention of the industry with different volume types.

According to the Ministry of Food and Drug Safety on the 14^th, Roche Korea has recently acquired approval of ‘Tamiflu Powd For Susp 5mg/ml(oseltamivir phosphate).’

Although acquiring approval of ‘Tami...